Bronchial Diseases  >>  Enbrel (etanercept)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Enbrel (etanercept) / Pfizer, Amgen
NCT00001893: Study of TNFR:Fc (Enbrel) in the Treatment of Asthma

Completed
2
150
US
TNFR:Fc
National Heart, Lung, and Blood Institute (NHLBI)
Asthma
12/02
 
NCT00141791 / 2004-003778-27: Study Evaluating Etanercept in Moderate to Severe Asthma

Completed
2
120
US
Etanercept
Wyeth is now a wholly owned subsidiary of Pfizer
Asthma
07/06
07/06
NCT00141726: Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant

Completed
2
34
US
Etanercept, Enbrel
University of Michigan Rogel Cancer Center
Lung Injury, Acute, Respiratory Distress Syndrome, Adult, Bronchiolitis Obliterans
07/08
02/09
NCT00029328: Etanercept for Non-Infectious Lung Injury Following Bone Marrow Transplantation

Completed
1/2
15
US
etanercept
FDA Office of Orphan Products Development
Respiratory Distress Syndrome, Adult, Bronchiolitis Obliterans, Pneumonia
 
09/03

Download Options